RESTON, Va.—An earlier indication of whether chemotherapy benefits non–small cell lung cancer patients—provided by positron emission tomography (PET) imaging—can guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine.>>> Discuss This Story
